Hikma Pharmaceuticals PLC

• Country

  United Kingdom

• Sector

  Health Care

• Industry group

  Pharmaceuticals, Biotechnology & Life Sciences

• Industry

  Pharmaceuticals

• Sub-sector

  Health Care

• Capitalization (millions of $)

  5020.7

• Ticker

  HKMPY.PK

• ISIN

  US4312881091

• IPO date

  2005-11-01

• Availability on Russian exchanges

  No

• Reporting for

  2024-03-22

• Date fact. publication of reports

  2023-12-31

Hikma Pharmaceuticals Plc is a pharmaceutical company. The Company is focused on developing, manufacturing, marketing and selling of a broad range of generic, branded and in-licensed pharmaceuticals products in solid, semi-solid, liquid and injectable final dosage forms. The Company's segments include Branded, Injectables, Generics and Others. The Company provides non-injectable and injectable generic medicines in the United States. It provides branded generic medicines and generic injectable products across the Middle East and North Africa (MENA). It also provides generic injectable medicines in Europe and other markets around the world. The Company's other businesses comprise Arab Medical Containers (AMC), a manufacturer of plastic specialized medicinal sterile containers, International Pharmaceuticals Research Centre, which conducts bio-equivalency studies, and the active pharmaceutical ingredient (API) manufacturing division of Hikma Pharmaceuticals Limited Jordan.